These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35845092)

  • 1. Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score.
    Nakamura T; Asanuma K; Hagi T; Sudo A
    J Inflamm Res; 2022; 15():3891-3899. PubMed ID: 35845092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of the high-sensitivity modified Glasgow prognostic score in predicting the survival of patients with a soft-tissue sarcoma.
    Nakamura T; Matsumine A; Asanuma K; Matsubara T; Sudo A
    Bone Joint J; 2015 Jun; 97-B(6):847-52. PubMed ID: 26033068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the modified Glasgow Prognostic Score aid in the management of patients undergoing surgery for a soft-tissue sarcoma? : an international multicentre study.
    Spence S; Doonan J; Farhan-Alanie OM; Chan CD; Tong D; Cho HS; Sahu MA; Traub F; Gupta S;
    Bone Joint J; 2022 Jan; 104-B(1):168-176. PubMed ID: 34969280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of High-Sensitivity Modified Glasgow Prognostic Score in Castration-Resistant Prostate Cancer Patients Who Received Docetaxel.
    Ando K; Sakamoto S; Saito S; Maimaiti M; Imamura Y; Sazuka T; Sato N; Komiya A; Anzai N; Ichikawa T
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer.
    Hanai N; Sawabe M; Kimura T; Suzuki H; Ozawa T; Hirakawa H; Fukuda Y; Hasegawa Y
    Oncotarget; 2018 Dec; 9(97):37008-37016. PubMed ID: 30651931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy].
    Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218
    [No Abstract]   [Full Text] [Related]  

  • 7. What is a useful marker for predicting survival in patients with high-grade soft tissue sarcoma who have non-inflammatory conditions?
    Nakamura T; Asanuma K; Hagi T; Sudo A
    J Orthop Sci; 2024 Jul; 29(4):1125-1129. PubMed ID: 37537113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score.
    Hirahara N; Matsubara T; Kaji S; Kawabata Y; Hyakudomi R; Yamamoto T; Uchida Y; Ishitobi K; Takai K; Tajima Y
    Oncotarget; 2020 Nov; 11(45):4169-4177. PubMed ID: 33227100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic role of the preoperative systemic immune-inflammation index and high-sensitivity modified Glasgow prognostic score in patients after radical operation for soft tissue sarcoma.
    Hou T; Guo T; Nie R; Hong D; Zhou Z; Zhang X; Liang Y
    Eur J Surg Oncol; 2020 Aug; 46(8):1496-1502. PubMed ID: 32576479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer.
    Takeno S; Hashimoto T; Shibata R; Maki K; Shiwaku H; Yamana I; Yamashita R; Yamashita Y
    Oncology; 2014; 87(4):205-14. PubMed ID: 25034097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modified Glasgow prognostic score in patients undergoing surgery for bone and soft tissue sarcoma.
    Morhij R; Mahendra A; Jane M; McMillan DC
    J Plast Reconstr Aesthet Surg; 2017 May; 70(5):618-624. PubMed ID: 28342782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study.
    Kasahara K; Enomoto M; Udo R; Tago T; Mazaki J; Ishizaki T; Yamada T; Nagakawa Y; Katsumata K; Tsuchida A
    BMC Cancer; 2022 Jan; 22(1):20. PubMed ID: 34980009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of Glasgow Prognostic Score and its modified scores on 5-year outcome in patients with coronary heart disease undergoing percutaneous coronary intervention.
    Li J; Yan K; Zhu P; Tang X; Yang Y; Gao R; Yuan J; Zhao X
    Heliyon; 2024 Sep; 10(18):e37317. PubMed ID: 39309905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
    Brown JT; Liu Y; Shabto JM; Martini DJ; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni LB; Joshi SS; Kissick H; Ogan K; Harris WB; Carthon BC; Kucuk O; Master VA; Bilen MA
    Oncologist; 2021 May; 26(5):397-405. PubMed ID: 33634507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Role of High-Sensitivity Modified Glasgow Prognostic Score for Patients With Operated Oral Cavity Cancer: A Retrospective Study.
    Tsai YT; Fang KH; Hsu CM; Lai CH; Chang SW; Huang EI; Tsai MS; Chang GH; Luan CW
    Front Oncol; 2022; 12():825967. PubMed ID: 35242712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity modified Glasgow prognostic score (HS-mGPS) Is superior to the mGPS in esophageal cancer patients treated with chemoradiotherapy.
    Chen P; Fang M; Wan Q; Zhang X; Song T; Wu S
    Oncotarget; 2017 Nov; 8(59):99861-99870. PubMed ID: 29245945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
    Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma.
    Tong T; Guan Y; Xiong H; Wang L; Pang J
    Front Oncol; 2020; 10():1541. PubMed ID: 33042799
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination of handgrip strength and high-sensitivity modified Glasgow prognostic score predicts survival outcomes in patients with colon cancer.
    Shi Y; Sun Y; Shen X; Yang Z; Xu B; Bao C
    Front Nutr; 2024; 11():1421560. PubMed ID: 39010859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of High-Sensitivity Modified Glasgow Prognostic Score in Cancer Prognosis: A Systemic Review and Meta-Analysis.
    Wu TH; Tsai YT; Chen KY; Yap WK; Luan CW
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.